Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Sample-Sparing Multiplexed ADCP Assay
Audrey L. Butler, Jonathan K. Fallon, Galit Alter
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
Emanuele Andreano, Emanuele Nicastri, Ida Paciello, et al.
Cell (2021) Vol. 184, Iss. 7, pp. 1821-1835.e16
Open Access | Times Cited: 219
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination
Matthew J. Gorman, Nita Patel, Mimi Guebre‐Xabier, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 9, pp. 100405-100405
Open Access | Times Cited: 129
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions
Paulina Kapłonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 645
Open Access | Times Cited: 122
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
Ahmed O. Hassan, Swathi Shrihari, Matthew J. Gorman, et al.
Cell Reports (2021) Vol. 36, Iss. 4, pp. 109452-109452
Open Access | Times Cited: 119
mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern
Paulina Kapłonek, Stephanie Fischinger, Deniz Cizmeci, et al.
Immunity (2022) Vol. 55, Iss. 2, pp. 355-365.e4
Open Access | Times Cited: 100
Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope
Arthur S. Kim, Natasha M. Kafai, Emma S. Winkler, et al.
Cell (2021) Vol. 184, Iss. 17, pp. 4414-4429.e19
Open Access | Times Cited: 56
Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines
Paulina Kapłonek, Yixiang Deng, Jessica Shih-Lu Lee, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 5, pp. 101048-101048
Open Access | Times Cited: 21
Waning immunity and IgG4 responses following bivalent mRNA boosting
Ninaad Lasrado, Ai‐ris Y. Collier, Jessica Miller, et al.
Science Advances (2024) Vol. 10, Iss. 8
Open Access | Times Cited: 13
Comparative study of acetalated-dextran microparticle fabrication methods for a clinically translatable subunit-based influenza vaccine
Erik S. Pena, Cole J. Batty, Dylan A. Hendy, et al.
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123836-123836
Closed Access | Times Cited: 7
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity
Kathryn Bowman, Daniel Stein, Sally Shin, et al.
mBio (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 29
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19
Paulina Kapłonek, Deniz Cizmeci, Gaurav Kwatra, et al.
Nature Immunology (2023) Vol. 24, Iss. 7, pp. 1161-1172
Open Access | Times Cited: 17
Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors
Rita E. Chen, Matthew J. Gorman, Daniel Y. Zhu, et al.
Med (2021) Vol. 2, Iss. 12, pp. 1327-1341.e4
Open Access | Times Cited: 36
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination
Matthew J. Gorman, Nita Patel, Mimi Guebre‐Xabier, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 32
Systems approach to define humoral correlates of immunity to Shigella
Biana Bernshtein, Esther Ndungo, Deniz Cizmeci, et al.
Cell Reports (2022) Vol. 40, Iss. 7, pp. 111216-111216
Open Access | Times Cited: 25
Chemoenzymatic Synthesis of a Rhamnose‐Functionalized Bispecific Nanobody as a Bispecific Antibody Mimic for Cancer Immunotherapy
Haofei Hong, Lin Han, Dan Li, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 38
Closed Access | Times Cited: 24
Vinyl Sulfone-functionalized Acetalated Dextran Microparticles as a Subunit Broadly Acting Influenza Vaccine
Cole J. Batty, Liubov M. Lifshits, Dylan A. Hendy, et al.
The AAPS Journal (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 13
Functional assays to evaluate antibody-mediated responses against Shigella: a review
Elena Boero, Giacomo Vezzani, Francesca Micoli, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 12
Replicon particle vaccination induces non-neutralizing anti-nucleoprotein antibody-mediated control of Crimean-Congo hemorrhagic fever virus
Teresa E. Sorvillo, Elif Karaaslan, Florine E. M. Scholte, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
High‐resolution definition of humoral immune response correlates of effective immunity against HIV
Galit Alter, Karen G. Dowell, Eric P. Brown, et al.
Molecular Systems Biology (2018) Vol. 14, Iss. 3
Open Access | Times Cited: 43
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
Ebene R. Haycroft, Samantha K. Davis, Pradhipa Ramanathan, et al.
Medical Microbiology and Immunology (2023) Vol. 212, Iss. 4, pp. 291-305
Open Access | Times Cited: 11
Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions
Florine E. M. Scholte, Ercan Karaaslan, Justin T. O’Neal, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
A panel of hepatitis C virus glycoproteins for the characterization of antibody responses using antibodies with diverse recognition and neutralization patterns
Ana Chumbe, Marloes Grobben, Joan Capella-Pujol, et al.
Virus Research (2024) Vol. 341, pp. 199308-199308
Open Access | Times Cited: 3
Determinants of immune responses predictive of protection against shigellosis in an endemic zone: a systems analysis of antibody profiles and function
Biana Bernshtein, Meagan Kelly, Deniz Cizmeci, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 10, pp. 100889-100889
Open Access | Times Cited: 3
Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates
Daniel Y. Zhu, Matthew J. Gorman, Dansu Yuan, et al.
PLoS Biology (2022) Vol. 20, Iss. 5, pp. e3001609-e3001609
Open Access | Times Cited: 16
Coronavac inactivated vaccine triggers durable, cross-reactive Fc-mediated phagocytosis activities
Lili Wang, Chuang Li, Wanting Li, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top